Menu
← Oncology Approval Tracker
FDA DECISION ·
Talzenna soft gelatin capsules
talazoparib tosylate · Pfizer
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Liquid-filled soft gelatin capsules for adults with qualifying germline BRCA-mutated, HER2-negative locally advanced or metastatic breast cancer, or with enzalutamide for HRR-mutated metastatic castration-resistant prostate cancer.
LAMPGEN ANALYSIS
Why it matters
The FDA approved a soft gelatin capsule formulation for the existing indications and strengths, based on a bridge to the earlier hard capsules.
What research teams should watch
Identify the capsule formulation and exact strength in pharmacy records while continuing regimen-specific dose adjustment and blood count monitoring.
PRIMARY RECORDS